{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:06:28Z","timestamp":1791983188628,"version":"4.4.0"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["18CDA34110361"],"award-info":[{"award-number":["18CDA34110361"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"NCATS","doi-asserted-by":"crossref","award":["UL1TR0001863"],"award-info":[{"award-number":["UL1TR0001863"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"crossref"}]},{"name":"YCCI","award":["KL2, TR001862"],"award-info":[{"award-number":["KL2, TR001862"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Cardiac magnetic resonance (CMR) global longitudinal strain and circumferential strain abnormalities have been associated with left ventricular ejection fraction (LVEF) reduction and cardiotoxicity from oncologic therapy. However, few studies have evaluated the associations of strain and cardiovascular outcomes.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Objectives<\/jats:title>\n<jats:p>To assess CMR circumferential and global longitudinal strain (GLS) correlations with cardiovascular outcomes including myocardial infarction, systolic dysfunction, diastolic dysfunction, arrhythmias and valvular disease in breast cancer patients treated with and without anthracyclines and\/or trastuzumab therapy.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Methods<\/jats:title>\n<jats:p>Breast cancer patients with a CMR from 2013\u20132017 at Yale New Haven Hospital were included. Patient co-morbidities, medications, and cardiovascular outcomes were obtained from chart review. Biostatistical analyses, including Pearson correlations, competing risk regression model, and competing risk survival curves comparing the two groups were analyzed.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Results<\/jats:title>\n<jats:p>116 breast cancer with CMRs were included in our analysis to assess differences between Anthracycline\/Trastuzumab (AT) (62) treated versus non anthracycline\/trastuzumab (NAT) (54) treated patients in terms of imaging characteristics and outcomes. More AT patients 17 (27.4%) developed systolic heart failure compared to the NAT group 6 (10.9%), p = 0.025. Statin use was associated with a significant reduction in future arrhythmias (HR 0.416; 95% CI 0.229\u20130.755, p = 0.004). In a sub-group of 13 patients that underwent stress CMR, we did not find evidence of microvascular dysfunction by sub-endocardial\/sub-epicardial myocardial perfusion index ratio after adjusting for ischemic heart disease.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec005\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>In our study, CMR detected signs of subclinical cardiotoxicity such as strain abnormalities despite normal LV function and abnormal circumferential strain was associated with adverse cardiovascular outcomes such as valvular disease and systolic heart failure. Thus, CMR is an important tool during and after cancer treatment to identity and prognosticate cancer treatment-related cardiotoxicity.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0286364","type":"journal-article","created":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T17:27:52Z","timestamp":1685467672000},"page":"e0286364","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Quantitative cardiovascular magnetic resonance findings and clinical risk factors predict cardiovascular outcomes in breast cancer patients"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4715-1848","authenticated-orcid":true,"given":"Jennifer M.","family":"Kwan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Arbune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana L.","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3023-1304","authenticated-orcid":true,"given":"Seohyuk","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Lopez-Mattei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avirup","family":"Guha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3807-0261","authenticated-orcid":true,"given":"Anna S.","family":"Bader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Meadows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Sinusas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Mojibian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Lustberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Hull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4173-3449","authenticated-orcid":true,"given":"Lauren A.","family":"Baldassarre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,5,30]]},"reference":[{"key":"pone.0286364.ref001","first-page":"438","article-title":"Breast cancer statistics, 2019","volume":"69","author":"CE DeSantis","year":"2019","journal-title":"CA: a cancer journal for clinicians"},{"key":"pone.0286364.ref002","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1002\/cncr.31638","article-title":"Trends in breast cancer mortality by stage at diagnosis among young women in the United States","volume":"124","author":"F Guo","year":"2018","journal-title":"Cancer"},{"key":"pone.0286364.ref003","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10549-018-4723-0","article-title":"The risk of cardiovascular disease following breast cancer by Framingham risk score","volume":"170","author":"SAM Gernaat","year":"2018","journal-title":"Breast cancer research and treatment"},{"key":"pone.0286364.ref004","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/EDE.0000000000000394","article-title":"Cardiovascular Disease Mortality Among Breast Cancer Survivors","volume":"27","author":"PT Bradshaw","year":"2016","journal-title":"Epidemiology (Cambridge, Mass)"},{"key":"pone.0286364.ref005","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/cncr.32648","article-title":"Causes of death after breast cancer diagnosis: A US population-based analysis","volume":"126","author":"AM Afifi","year":"2020","journal-title":"Cancer"},{"key":"pone.0286364.ref006","first-page":"190","article-title":"The prevention of cardiovascular disease in cancer survivors","volume":"39","author":"IN Daher","year":"2012","journal-title":"Texas Heart Institute journal"},{"key":"pone.0286364.ref007","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1161\/CIR.0000000000000556","article-title":"Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association","volume":"137","author":"LS Mehta","year":"2018","journal-title":"Circulation"},{"key":"pone.0286364.ref008","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/HCO.0000000000000767","article-title":"Opportunities for improved cardiovascular disease prevention in oncology patients","volume":"35","author":"K Bravo-Jaimes","year":"2020","journal-title":"Curr Opin Cardiol"},{"key":"pone.0286364.ref009","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/ehjci\/jeu192","article-title":"Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"15","author":"JC Plana","year":"2014","journal-title":"European heart journal Cardiovascular Imaging"},{"key":"pone.0286364.ref010","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jcmg.2018.06.005","article-title":"Cardiotoxicity and Cardiac Monitoring Among Chemotherapy-Treated Breast Cancer Patients","volume":"11","author":"ML Henry","year":"2018","journal-title":"JACC Cardiovascular imaging"},{"key":"pone.0286364.ref011","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2174\/157340311799960645","article-title":"Anthracycline cardiotoxicity: prevalence, pathogenesis and treatment","volume":"7","author":"M Volkova","year":"2011","journal-title":"Curr Cardiol Rev"},{"key":"pone.0286364.ref012","first-page":"227","article-title":"Anthracycline cardiotoxicity after breast cancer treatment","volume":"23","author":"DL Hershman","year":"2009","journal-title":"Oncology (Williston Park, NY)"},{"key":"pone.0286364.ref013","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10549-019-05303-y","article-title":"HER2+ breast cancer treatment and cardiotoxicity: monitoring and management","volume":"177","author":"G Jerusalem","year":"2019","journal-title":"Breast cancer research and treatment"},{"key":"pone.0286364.ref014","doi-asserted-by":"crossref","first-page":"S4351","DOI":"10.21037\/jtd.2018.10.92","article-title":"Cardiovascular imaging in cardio-oncology","volume":"10","author":"AA Mahabadi","year":"2018","journal-title":"J Thorac Dis"},{"key":"pone.0286364.ref015","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS): Developed by the task force on cardio-oncology of the European Society of Cardiology (ESC)","volume":"43","author":"AR Lyon","year":"2022","journal-title":"European Heart Journal"},{"key":"pone.0286364.ref016","doi-asserted-by":"crossref","DOI":"10.1177\/1179546819866445","article-title":"Cancer Therapy-Related Cardiac Dysfunction: An Overview for the Clinician","volume":"13","author":"IE Perez","year":"2019","journal-title":"Clin Med Insights Cardiol"},{"key":"pone.0286364.ref017","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1158\/1078-0432.CCR-09-0628","article-title":"Adjuvant trastuzumab induces ventricular remodeling despite aerobic exercise training","volume":"15","author":"MJ Haykowsky","year":"2009","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"key":"pone.0286364.ref018","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2147\/IJWH.S68745","article-title":"The utility of cardiac stress testing for detection of cardiovascular disease in breast cancer survivors: a systematic review","volume":"7","author":"AA Kirkham","year":"2015","journal-title":"Int J Womens Health"},{"key":"pone.0286364.ref019","unstructured":"Network NCC. NCCN clinical practice guidelines in oncology. 2008."},{"key":"pone.0286364.ref020","doi-asserted-by":"crossref","first-page":"64","DOI":"10.15420\/ecr.2017:17:2","article-title":"Cardio-oncology: A Focus on Cardiotoxicity","volume":"13","author":"A Koutsoukis","year":"2018","journal-title":"Eur Cardiol"},{"key":"pone.0286364.ref021","doi-asserted-by":"crossref","first-page":"e5195","DOI":"10.1097\/MD.0000000000005195","article-title":"Risk factors of trastuzumab-induced cardiotoxicity in breast cancer: A meta-analysis","volume":"95","author":"Z Jawa","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"pone.0286364.ref022","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.jcmg.2018.06.004","article-title":"Cardiovascular Magnetic Resonance in the Oncology Patient","volume":"11","author":"JH Jordan","year":"2018","journal-title":"JACC Cardiovascular imaging"},{"key":"pone.0286364.ref023","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jcmg.2012.11.017","article-title":"Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease","volume":"6","author":"BC Drafts","year":"2013","journal-title":"JACC Cardiovascular imaging"},{"key":"pone.0286364.ref024","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/ejechocard\/jer187","article-title":"Two-dimensional myocardial strain imaging detects changes in left ventricular systolic function immediately after anthracycline chemotherapy","volume":"12","author":"PW Stoodley","year":"2011","journal-title":"European journal of echocardiography: the journal of the Working Group on Echocardiography of the European Society of Cardiology"},{"key":"pone.0286364.ref025","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1067\/mhj.2001.115436","article-title":"Subclinical cardiotoxic effects of anthracyclines as assessed by magnetic resonance imaging-a pilot study","volume":"141","author":"R Wassmuth","year":"2001","journal-title":"American heart journal"},{"key":"pone.0286364.ref026","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1524-4741.2011.01101.x","article-title":"Lack of uniformity in cardiac assessment during trastuzumab therapy","volume":"17","author":"M Subar","year":"2011","journal-title":"The breast journal"},{"key":"pone.0286364.ref027","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1016\/j.jacc.2014.01.073","article-title":"Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review","volume":"63","author":"P Thavendiranathan","year":"2014","journal-title":"Journal of the American College of Cardiology"},{"key":"pone.0286364.ref028","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/ehjci\/jet159","article-title":"Use of speckle strain to assess left ventricular responses to cardiotoxic chemotherapy and cardioprotection","volume":"15","author":"K Negishi","year":"2014","journal-title":"European heart journal Cardiovascular Imaging"},{"key":"pone.0286364.ref029","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s10741-020-09938-8","article-title":"Right ventricular involvement in cancer therapy-related cardiotoxicity: the emerging role of strain echocardiography","volume":"26","author":"K Keramida","year":"2021","journal-title":"Heart failure reviews"},{"key":"pone.0286364.ref030","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jacc.2020.11.020","article-title":"Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy","volume":"77","author":"P Thavendiranathan","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"pone.0286364.ref031","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.734820","article-title":"Clinical Impact of Cardiovascular Magnetic Resonance in Cancer Patients With Suspected Cardiomyopathy","volume":"8","author":"G Heidari-Bateni","year":"2021","journal-title":"Frontiers in Cardiovascular Medicine"},{"key":"pone.0286364.ref032","first-page":"e012459","article-title":"Multiparametric Early Detection and Prediction of Cardiotoxicity Using Myocardial Strain, T1 and T2 Mapping, and Biochemical Markers: A Longitudinal Cardiac Resonance Imaging Study During 2 Years of Follow-Up","volume":"14","author":"S Giusca","year":"2021","journal-title":"Circulation: Cardiovascular Imaging"},{"key":"pone.0286364.ref033","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1161\/CIRCIMAGING.113.000899","article-title":"Cardiac MRI in the assessment of cardiac injury and toxicity from cancer chemotherapy: a systematic review","volume":"6","author":"P Thavendiranathan","year":"2013","journal-title":"Circulation Cardiovascular imaging"},{"key":"pone.0286364.ref034","doi-asserted-by":"crossref","first-page":"e008777","DOI":"10.1161\/CIRCIMAGING.118.008777","article-title":"Early Detection of Anthracycline-Induced Cardiotoxicity in Breast Cancer Survivors With T2 Cardiac Magnetic Resonance","volume":"12","author":"MB Lustberg","year":"2019","journal-title":"Circulation Cardiovascular imaging"},{"key":"pone.0286364.ref035","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/ehf2.12277","article-title":"Native myocardial T1 time can predict development of subsequent anthracycline-induced cardiomyopathy","volume":"5","author":"F Muehlberg","year":"2018","journal-title":"ESC heart failure"},{"key":"pone.0286364.ref036","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jacc.2019.11.049","article-title":"Global Longitudinal Strain and Cardiac Events in Patients With Immune Checkpoint Inhibitor-Related Myocarditis","volume":"75","author":"M Awadalla","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"pone.0286364.ref037","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12947-021-00266-x","article-title":"2D-echocardiography vs cardiac MRI strain: a prospective cohort study in patients with HER2-positive breast cancer undergoing trastuzumab","volume":"19","author":"NI Bouwer","year":"2021","journal-title":"Cardiovascular ultrasound"},{"key":"pone.0286364.ref038","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12968-019-0559-y","article-title":"Echocardiography and cardiovascular magnetic resonance based evaluation of myocardial strain and relationship with late gadolinium enhancement","volume":"21","author":"J Erley","year":"2019","journal-title":"J Cardiovasc Magn Reson"},{"key":"pone.0286364.ref039","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.amjcard.2012.11.022","article-title":"Myocardial extracellular volume by cardiac magnetic resonance imaging in patients treated with anthracycline-based chemotherapy","volume":"111","author":"TG Neilan","year":"2013","journal-title":"The American journal of cardiology"},{"key":"pone.0286364.ref040","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s12872-020-01497-y","article-title":"Cardiotoxicity evaluation using magnetic resonance imaging in breast Cancer patients (CareBest): study protocol for a prospective trial","volume":"20","author":"YJ Hong","year":"2020","journal-title":"BMC cardiovascular disorders"},{"key":"pone.0286364.ref041","first-page":"196","article-title":"MRI-Derived Myocardial Strain Measures in Normal Subjects","volume":"11","author":"HQ Vo","year":"2018","journal-title":"JACC: Cardiovascular Imaging"},{"key":"pone.0286364.ref042","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1158\/1078-0432.CCR-06-1210","article-title":"Cumulative incidence in competing risks data and competing risks regression analysis","volume":"13","author":"HT Kim","year":"2007","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"key":"pone.0286364.ref043","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s10554-011-9982-3","article-title":"Endocardial and epicardial myocardial perfusion determined by semi-quantitative and quantitative myocardial perfusion magnetic resonance","volume":"28","author":"A Larghat","year":"2012","journal-title":"Int J Cardiovasc Imaging"},{"key":"pone.0286364.ref044","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jaccao.2020.03.002","article-title":"Cardiotoxicity Surveillance and Risk of Heart Failure During HER2 Targeted Therapy","volume":"2","author":"AF Yu","year":"2020","journal-title":"JACC CardioOncol"},{"key":"pone.0286364.ref045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225829","article-title":"Global longitudinal strain can predict heart failure exacerbation in stable outpatients with ischemic left ventricular systolic dysfunction","volume":"14","author":"D Kaufmann","year":"2019","journal-title":"PloS one"},{"key":"pone.0286364.ref046","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.jacc.2017.12.046","article-title":"Diagnosis of Microvascular Angina Using Cardiac Magnetic Resonance","volume":"71","author":"A Liu","year":"2018","journal-title":"Journal of the American College of Cardiology"},{"key":"pone.0286364.ref047","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.amjcard.2006.03.064","article-title":"Risk of venous thromboembolism in patients hospitalized with heart failure","volume":"98","author":"A Beemath","year":"2006","journal-title":"The American journal of cardiology"},{"key":"pone.0286364.ref048","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/clc.20669","article-title":"Statins as antiarrhythmics: a systematic review part I: effects on risk of atrial fibrillation","volume":"32","author":"H Abuissa","year":"2009","journal-title":"Clinical cardiology"},{"key":"pone.0286364.ref049","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.jacc.2007.09.063","article-title":"Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials","volume":"51","author":"L Fauchier","year":"2008","journal-title":"Journal of the American College of Cardiology"},{"key":"pone.0286364.ref050","unstructured":"ACC. STOP-CA Trial: Statin Therapy Associated With Reduced Heart Dysfunction From Anthracyclines. 2023."},{"key":"pone.0286364.ref051","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.jacc.2022.08.743","article-title":"Advances in Multimodality Imaging in Cardio-Oncology","volume":"80","author":"A Baldassarre Lauren","year":"2022","journal-title":"Journal of the American College of Cardiology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0286364","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T17:28:38Z","timestamp":1685467718000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0286364"}},"subtitle":[],"editor":[{"given":"Raffaele","family":"Bugiardini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,5,30]]},"references-count":51,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0286364","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,30]]}}}